False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise

52Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Erythropoietin (Epo) is a glycoprotein hormone that promotes the production of red blood cells. Recombinant human Epo (rhEpo) is illicitly used to improve performance in endurance sports. Doping in sports is discouraged by the screening of athletes for rhEPO in urine. The adopted test is based on a combination of isoelectric focusing and double immunoblotting, and distinguishes between endogenous and recombinant human Epo. We show here that this widely used test can occasionally lead to the false-positive detection of rhEpo (epoetin-β) in postexercise, protein-rich urine, probably because the adopted monoclonal anti-Epo antibodies are not monospecific. © 2006 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Beullens, M., Delanghe, J. R., & Bollen, M. (2006). False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood, 107(12), 4711–4713. https://doi.org/10.1182/blood-2006-01-0028

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free